SETTING: Treatment of multidrug-resistant tuberculosis (MDR-TB) is often based on drug susceptibility testing (DST) results; for this reason, rapid, simple DST methods are sought which could be applied in resource-poor countries. One such method is a nitrate reductase colorimetric assay known as the Griess method. In Peru, where the incidence rate of TB is among the highest in South America, the National Institute of Health recently undertook the validation and implementation of the direct Griess method. OBJECTIVE: To describe the process of validation and implemention of the direct Griess method at the Peruvian National Institute of Health. DESIGN: Prospective study comparing the sensitivity and specificity of the direct Griess method with the Löwenstein-Jensen proportion method in determining resistance to isoniazid (INH) and rifampin (RMP) among clinical isolates. RESULTS: Among 192 specimens, the sensitivity and specificity of the Griess method for detection of INH resistance was 99.1% and 100%, respectively. For identification of RMP resistance, the sensitivity and specificity was 93.5% and 100%, respectively. CONCLUSIONS: In addition to its high sensitivity and specificity and rapid turn around time, the Griess method uses simple, inexpensive reagents and requires minimal laboratory space and technical expertise, thus providing an ideal screening tool for resource-poor settings with high rates of MDR-TB.
SETTING: Treatment of multidrug-resistant tuberculosis (MDR-TB) is often based on drug susceptibility testing (DST) results; for this reason, rapid, simple DST methods are sought which could be applied in resource-poor countries. One such method is a nitrate reductase colorimetric assay known as the Griess method. In Peru, where the incidence rate of TB is among the highest in South America, the National Institute of Health recently undertook the validation and implementation of the direct Griess method. OBJECTIVE: To describe the process of validation and implemention of the direct Griess method at the Peruvian National Institute of Health. DESIGN: Prospective study comparing the sensitivity and specificity of the direct Griess method with the Löwenstein-Jensen proportion method in determining resistance to isoniazid (INH) and rifampin (RMP) among clinical isolates. RESULTS: Among 192 specimens, the sensitivity and specificity of the Griess method for detection of INH resistance was 99.1% and 100%, respectively. For identification of RMP resistance, the sensitivity and specificity was 93.5% and 100%, respectively. CONCLUSIONS: In addition to its high sensitivity and specificity and rapid turn around time, the Griess method uses simple, inexpensive reagents and requires minimal laboratory space and technical expertise, thus providing an ideal screening tool for resource-poor settings with high rates of MDR-TB.
Authors: Joia S Mukherjee; Michael L Rich; Adrienne R Socci; J Keith Joseph; Felix Alcántara Virú; Sonya S Shin; Jennifer J Furin; Mercedes C Becerra; Donna J Barry; Jim Yong Kim; Jaime Bayona; Paul Farmer; Mary C Smith Fawzi; Kwonjune J Seung Journal: Lancet Date: 2004-02-07 Impact factor: 79.321
Authors: G Canetti; W Fox; A Khomenko; H T Mahler; N K Menon; D A Mitchison; N Rist; N A Smelev Journal: Bull World Health Organ Date: 1969 Impact factor: 9.408
Authors: M C Becerra; J Freeman; J Bayona; S S Shin; J Y Kim; J J Furin; B Werner; A Sloutsky; R Timperi; M E Wilson; M Pagano; P E Farmer Journal: Int J Tuberc Lung Dis Date: 2000-02 Impact factor: 2.373
Authors: E E Telzak; K Sepkowitz; P Alpert; S Mannheimer; F Medard; W el-Sadr; S Blum; A Gagliardi; N Salomon; G Turett Journal: N Engl J Med Date: 1995-10-05 Impact factor: 91.245
Authors: Joaquín A Blaya; Sonya Shin; Carmen Contreras; Gloria Yale; Carmen Suarez; Luis Asencios; Jihoon Kim; Pablo Rodriguez; Peter Cegielski; Hamish S F Fraser Journal: J Am Med Inform Assoc Date: 2010-11-27 Impact factor: 4.497
Authors: M Yagui; M T Perales; L Asencios; L Vergara; C Suarez; G Yale; C Salazar; M Saavedra; S Shin; O Ferrousier; P Cegielski Journal: Int J Tuberc Lung Dis Date: 2006-08 Impact factor: 2.373
Authors: Alberto Mendoza-Ticona; David A J Moore; Valentina Alarcón; Frine Samalvides; Carlos Seas Journal: Rev Peru Med Exp Salud Publica Date: 2013-04
Authors: Vivian Kawai; Giselle Soto; Robert H Gilman; Christian T Bautista; Luz Caviedes; Luz Huaroto; Eduardo Ticona; Jaime Ortiz; Marco Tovar; Victor Chavez; Richard Rodriguez; A Roderick Escombe; Carlton A Evans Journal: Am J Trop Med Hyg Date: 2006-12 Impact factor: 2.345
Authors: H Lin; S Shin; J A Blaya; Z Zhang; P Cegielski; C Contreras; L Asencios; C Bonilla; J Bayona; C J Paciorek; T Cohen Journal: Epidemiol Infect Date: 2010-12-23 Impact factor: 2.451
Authors: S S Shin; L Asencios; M Yagui; G Yale; C Suárez; J Bayona; C Bonilla; O Jave; C C Contreras; S Atwood; J A Blaya; J Ershova; J P Cegielski Journal: Int J Tuberc Lung Dis Date: 2012-09-14 Impact factor: 2.373
Authors: L Asencios; G Yale; M Yagui; N Quispe; A Taylor; J Blaya; C Contreras; P Cegielski; J Bayona; C Bonilla; S Shin Journal: Int J Tuberc Lung Dis Date: 2008-07 Impact factor: 2.373